Is Targeted Therapy Painful? — What the Treatment Actually Feels Like
The fear of pain is one of the first things people ask about when targeted therapy is recommended. For most people, the treatment itself is not painful — it usually means taking a tablet at home, not attending a ward with a drip. Side effects are real, but they are different from what many families expect.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Not an infusion for most — Most targeted therapies are tablets taken at home — not drips in a clinic.
- Side effects, not pain — Skin reactions, fatigue, and gut changes are more common than physical pain.
- Different from chemotherapy — Severe hair loss and intense nausea are not the main features of targeted therapy.
- Varies by drug — What you feel depends on which targeted drug your oncologist prescribes for your cancer type.
on Panel
Survival Rate*
Treated
(800+ reviews)
Targeted therapy is not usually painful. Most forms are tablets or capsules you take at home — not infusions or injections given in hospital. Side effects such as skin rashes, fatigue, and diarrhoea are common, but severe physical pain during treatment is not the typical experience. What you feel depends on which drug you are taking.
What will you actually feel during targeted therapy?
For most people, targeted therapy means taking a tablet or capsule at home every day. There is no cannula, no drip, and no ward visit on treatment days.
The side effects are real but different from what most people expect if they have seen chemotherapy. Severe hair loss and intense nausea are not the main features. Skin reactions, diarrhoea, and fatigue are more typical, and they vary by drug.
Some drugs cause a rash that looks like acne, usually across the face and upper body. Others cause loose motions, mouth tenderness, or joint stiffness. These are manageable, especially when you report them to your team early.
Physical pain — the kind that makes you dread the next dose — is not the common experience. What most people describe is a change in energy, some skin or gut disruption, and a period of adjustment in the first weeks.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
Did you know?
Most targeted therapies are taken as daily tablets at home — not infusions in a clinic. Treatment days look like ordinary days for many people: no ward, no drip, and no recovery time after.
ESMO identifies the shift to oral cancer medicines as one of the most meaningful changes in the practical experience of cancer care over the past two decades.
Source: ESMO Patient Guides — Targeted Therapies in Cancer
Explore 119 more Targeted Therapy Basics, Testing & Your Cancer Type topics
Foundations & How Targeted Therapy Works
- Adjuvant and Neoadjuvant Targeted Therapy: Treatment Before or After Surgery
- Antibody-Drug Conjugates (ADCs): The Smart Bombs of Cancer Treatment
- Biosimilars and Generic Targeted Therapy Drugs: What They Are
- Can Targeted Therapy Be Combined with Chemotherapy or Radiation?
- Can Targeted Therapy Cure Cancer? An Honest Answer
- First-Line, Second-Line and Beyond: How Treatment Lines Work
- How Doctors Decide Between Chemo, Immunotherapy and Targeted Therapy
- How Does Targeted Therapy Actually Work? Explained Without Jargon
- How Long Does Targeted Therapy Take to Start Working?
- Is Targeted Therapy Painful? What the Treatment Actually Feels Like
- Is Targeted Therapy a Type of Chemotherapy? Clearing Up the Confusion
- Oral Tablets vs IV Infusion Targeted Therapy: What's the Difference?
- Precision Oncology vs Personalised Medicine: Are They the Same Thing?
- Targeted Therapy Success Rates: What the Numbers Really Mean
- Targeted Therapy for Stage 4 Cancer: What You Can Realistically Expect
- Targeted Therapy vs Chemotherapy: 12 Differences That Actually Matter
- Targeted Therapy vs Immunotherapy: Which One Is Right for You?
- The 8 Main Types of Targeted Therapy Drugs (With Examples)
- What Do Cancer Drug Endings Like -nib, -mab and -tinib Mean?
- What Is Targeted Therapy for Cancer? A Complete Patient Guide
- Which Cancers Can Be Treated with Targeted Therapy? Full List
- Why Didn't My Doctor Recommend Targeted Therapy for Me?
Before You Start - Preparation & Baseline
- 25 Questions to Ask Your Oncologist Before Starting Targeted Therapy
- Before You Start Targeted Therapy: The Complete Preparation Checklist
- Dental Check-Up Before Cancer Treatment: Why It Matters
- Financial Planning Before Starting Long-Term Targeted Therapy
- How Long After Surgery Can You Start Targeted Therapy?
- How to Store Your Targeted Therapy Tablets Correctly
- Setting Up a Dosing Routine You Won't Forget
- Should Targeted Therapy Be Taken With Food or on an Empty Stomach?
- Vaccinations Before and During Cancer Treatment
- What to Expect in Your First Month on Targeted Therapy
- Which Baseline Tests Are Done Before Starting a TKI?
- Which of Your Existing Medicines Must Stop Before Targeted Therapy
- Why You Need an ECHO and ECG Before Certain Cancer Drugs
Biomarker & Molecular Testing
- Can Mutation Testing Be Done on an Old Biopsy Block or Slides?
- Cost of NGS and Mutation Testing in India: 2026 Price Guide
- Do I Need Genetic Testing Before Starting Targeted Therapy?
- Germline vs Somatic Testing: The Difference Nobody Explains Properly
- Getting a Second Opinion on Your Genomic Report
- How Long Do Mutation Test Results Take in India? Realistic Timelines
- How to Read Your Molecular Pathology Report, Line by Line
- IHC, FISH, PCR or NGS: Which Mutation Test Is Right for Your Cancer?
- Is Mutation Testing Worth It If I Can't Afford the Drug?
- Liquid Biopsy vs Tissue Biopsy: Which Test Do You Need?
- My Report Says a Mutation Is 'Actionable': What Does That Mean?
- No Mutation Found in My Report: What Are My Options Now?
- Should I Start Chemotherapy While Waiting for Mutation Results?
- Should You Repeat Molecular Testing After Your Cancer Progresses?
- Single-Gene Test or Full Panel? How to Choose Without Wasting Money
- What Are PD-L1, TMB and MSI, and Do They Affect Targeted Therapy?
- What Does 'Variant of Uncertain Significance' (VUS) Mean?
- What Happens If There Isn't Enough Tissue for Mutation Testing?
- What Is NGS (Next-Generation Sequencing) Testing in Cancer?
- What Is a Molecular Tumour Board and Why Should You Want One?
- Which Cancers Should Always Be Tested for Mutations? A Checklist
- ctDNA and MRD Testing: Tracking Cancer Through a Blood Test
Cancer-Type Specific Targeted Therapy
- CML Treatment with TKIs: Living a Normal Life Span
- Cancer of Unknown Primary: Can Molecular Testing Help?
- GIST Treatment: Why This Cancer Changed Targeted Therapy Forever
- Targeted Therapy for Bile Duct Cancer (Cholangiocarcinoma)
- Targeted Therapy for Bladder and Urothelial Cancer
- Targeted Therapy for Brain Tumours and Glioma
- Targeted Therapy for Breast Cancer: HER2, HR+ and Triple Negative
- Targeted Therapy for CLL and Lymphoma
- Targeted Therapy for Cervical and Endometrial Cancer
- Targeted Therapy for Childhood Cancers
- Targeted Therapy for Colorectal Cancer: RAS, BRAF and HER2
- Targeted Therapy for Head and Neck Cancer
- Targeted Therapy for Kidney Cancer (RCC)
- Targeted Therapy for Liver Cancer (HCC)
- Targeted Therapy for Lung Cancer: Every Mutation and Drug Explained
- Targeted Therapy for Melanoma: BRAF and MEK Inhibitors
- Targeted Therapy for Multiple Myeloma
- Targeted Therapy for Neuroendocrine Tumours
- Targeted Therapy for Ovarian Cancer: PARP Inhibitors and Beyond
- Targeted Therapy for Pancreatic Cancer: Limited but Real Options
- Targeted Therapy for Prostate Cancer
- Targeted Therapy for Sarcoma
- Targeted Therapy for Stomach and Gastroesophageal Cancer
- Targeted Therapy for Thyroid Cancer
- Targeted Therapy in AML: Beyond Standard Chemotherapy
- Tumour-Agnostic Drugs: When the Mutation Matters More Than the Organ
Mutation & Target-Specific Pages
- ALK-Positive Lung Cancer: Drugs, Response and What Comes Next
- Antiangiogenic Drugs (VEGF Inhibitors): How Starving a Tumour Works
- BCR-ABL and the Philadelphia Chromosome in CML
- BRAF V600E Mutation: Targeted Therapy Across Multiple Cancers
- BRCA vs HRD Testing: Which One Determines PARP Inhibitor Eligibility?
- BRCA1 and BRCA2 Mutations in Cancer Treatment: PARP Inhibitors
- BTK Inhibitors in CLL and Lymphoma
- CD20, CD38 and Other Antibody Targets in Blood Cancers
- CDK4/6 Inhibitors in Hormone-Positive Breast Cancer
- Co-Mutations: When You Have Two Mutations at Once
- EGFR Exon 20 Insertion: Why It's Different and Harder to Treat
- EGFR Mutation in Lung Cancer: Complete Patient Guide
- ESR1 Mutation: Why Your Hormone Therapy Stopped Working
- FGFR Alterations in Bladder and Bile Duct Cancer
- FLT3 Mutation in AML: What It Means for Your Prognosis
- HER2 Mutation in Lung and Gastric Cancer
- HER2-Low Breast Cancer: A New Category That Changes Treatment
- HER2-Positive Breast Cancer: The Full Targeted Therapy Roadmap
- IDH1 and IDH2 Mutations in Glioma, AML and Bile Duct Cancer
- KIT and PDGFRA Mutations in GIST
- KRAS G12C Mutation: The Target That Was Undruggable for 40 Years
- KRAS Mutation but Not G12C: What Are My Options?
- MET Exon 14 Skipping and MET Amplification Explained
- MSI-High and Mismatch Repair Deficiency: Testing and Treatment
- NRG1, MET, RET and Other Rare Fusions: Where to Get Tested
- NTRK Fusion: One Drug for Many Different Cancers
- Osimertinib: What to Expect, Side Effects and How Long It Works
- PALB2, ATM and Other BRCA-Like Genes: Do They Get the Same Drugs?
- PIK3CA Mutation in Breast Cancer: Alpelisib and What to Expect
- PSMA and AR-Targeted Therapy in Prostate Cancer
- RET Fusion Cancer: Lung, Thyroid and Beyond
- ROS1-Positive Cancer: A Rare Mutation with Excellent Options
- TP53 Mutation: Why There's Still No Targeted Drug for It
- Understanding Variant Allele Frequency (VAF) in Your Report
- What If My Mutation Has No Approved Drug Yet?
- mTOR Inhibitors in Cancer: Everolimus and Temsirolimus
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Is targeted therapy painful to take every day?
For most people, no. Tablets and capsules cause no sensation when you swallow them. Occasional joint stiffness, bone aches, or skin tenderness are reported with some targeted drugs, and if you feel consistent pain that is not settling, tell your team. Pain during treatment is not something to simply wait out — it is a signal worth reporting so your team can assess whether it is a side effect, something unrelated, or something that needs managing.
Does targeted therapy cause nausea the way chemotherapy does?
Nausea can occur but is generally milder than with many chemotherapy regimens. Taking the tablet with a small amount of food, rather than on an empty stomach, often reduces stomach discomfort significantly. Some people experience no nausea at all. If it is affecting your ability to eat or your daily life, tell your team — there are effective medicines that help, and you should not simply endure it as a fixed feature of treatment.
Will I lose my hair on targeted therapy?
Full hair loss — the kind strongly associated with many chemotherapy drugs — is not a typical feature of targeted therapy. Some targeted drugs may cause hair thinning or changes in texture, but most people keep their hair. Your oncologist can tell you what to expect from your specific drug, because this varies considerably between agents.
What is the skin rash from targeted therapy, and is it dangerous?
A rash resembling acne — often across the face, chest, and upper back — is a well-recognised side effect of certain targeted drugs, particularly those that act on the EGFR pathway. It is not an allergy and not dangerous in most cases, but it can be uncomfortable and affects how you feel about going out. Your team can prescribe creams and antibiotics that manage it effectively. Report it early, before it becomes severe, so the right treatment can start promptly.
How tired will I feel on targeted therapy?
Fatigue is one of the most commonly reported side effects across many targeted drugs. It is usually less dramatic than chemotherapy fatigue, and most people find ways to pace themselves through it, but it is real and worth planning for. If your energy drops to the point where you cannot do the things you need to do, tell your team — fatigue sometimes reflects an underlying issue such as anaemia that has a direct treatment rather than something you simply have to accept.
Can I take targeted therapy at home, or do I have to come to a clinic every day?
Most targeted therapies are oral — a tablet or capsule you take at home on a daily or twice-daily schedule. You will need clinic visits for blood tests and review at intervals, and some targeted agents are given as infusions, but the majority of people on targeted therapy do not need to attend a ward every treatment day. Your oncologist will confirm what your specific drug requires so you can plan around it.
Are there good days and bad days, or will I feel unwell every single day?
Most people find that side effects are not constant. They tend to be more noticeable in the first weeks as your body adjusts, and settle into a more predictable pattern over time. Most people have good days and difficult days rather than feeling equally unwell throughout. If you are feeling progressively worse over time rather than the same or better, that is worth discussing with your team — it is not something to accept as normal.
How is the experience of targeted therapy different from chemotherapy?
Chemotherapy typically targets all rapidly dividing cells, which is why hair loss, severe nausea, and low blood counts are so common. Targeted therapy acts on specific molecular pathways in cancer cells, so the side effects are different in character — skin reactions, diarrhoea, and liver changes are more typical than the effects most people associate with cancer treatment. Many people find targeted therapy more tolerable overall, but this varies considerably between drugs and individuals, and the two are not comparable on a single scale.